March 17, 2025 - 23:55

MINNEAPOLIS, March 17, 2025—DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for acute ischemic stroke and preeclampsia, has released its financial results for the year ending December 31, 2024. The company outlined its strategic initiatives and progress made over the past year, highlighting advancements in their clinical programs.
With a focus on addressing significant unmet medical needs, DiaMedica has made strides in its research efforts, particularly in the areas of acute ischemic stroke and preeclampsia. The company is committed to advancing its pipeline and believes that its innovative therapies have the potential to transform patient outcomes.
To further discuss these developments and the financial results, management will conduct a conference call on Tuesday, March 18, 2025, at 8:00 AM Eastern Time. This call will provide an opportunity for stakeholders to gain insights into the company’s future plans and ongoing projects.
April 19, 2026 - 01:19
I was laid off in 2020. My uncle's inheritance changed everything.A life-changing inheritance has propelled one entrepreneur from a sudden layoff to the brink of a major business milestone. After being laid off in 2020, Steph Mahon faced an uncertain future. That...
April 18, 2026 - 07:38
Concerns grow along Boulder Highway over unhoused impacts on businessesA stretch of Boulder Highway is at the center of increasing unease, as local business owners report that challenges stemming from the unhoused population are escalating and directly affecting their...
April 17, 2026 - 19:16
How Online Retail Innovations Are Driving U.S. Small Business ExportsA quiet revolution is taking place in U.S. small business exports, fueled not by traditional trade delegations, but by digital innovation. Online retail platforms and e-commerce tools are...
April 17, 2026 - 01:45
Business leaders erupt over Mamdani's luxury second-home tax in NYCA bold new legislative proposal in New York aimed at the ultra-wealthy has drawn fierce opposition from prominent business leaders and real estate interests. The measure, championed by Governor...